Minaris Regenerative Medicine is a global contract development and manufacturing organization for the production of cell and gene therapy products. We offer our clients clinical and commercial manufacturing services, development solutions, and technologies.

With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies.

At Minaris, we are creating cell therapy miracles together. 

Minaris Regenerative Medicine is wholly owned by the Resonac Group.

Biotechnology

Life Sciences

Manufacturing

Medical Devices

Minaris Regenerative Medicine

Hiroto Bando

Renate Sporrer

William Burckardt

Luz Rodgers

Luc St - Onge

Takuya Muramoto

Prakash Manwani

The Leadership Team at Minaris Regenerative Medicine spearheads the strategic direction, operational efficiency, and global market positioning of the company. Comprising key executives such as the Chief Operating Officer, Global Head of Sales and Marketing, and CEO, among others, the team collaborates to ensure robust clinical and commercial manufacturing services. They drive innovation, uphold high-quality standards, and foster organizational development to sustain Minaris' standing as a trusted partner in the cell and gene therapy industry worldwide.

Leadership Team

Quality Control and Assurance

Human Resources

Leadership Team

About

Team members

Other teams at Minaris Regenerative Medicine

Quality Control and Assurance

Human Resources